Quality growth rarely comes cheap, but Wall Street seems to have taken it a little too far in the case of Athenahealth (NASDAQ: ATHN )
. The ambulatory care market is still a growth opportunity, and the
company is only just beginning to develop products that can seriously
address the acute care market. Even so, it will take truly remarkable
growth and share gains for Athenahealth to grow into its current
valuation.
Read more here:
Does Athenahealth Inc's Growth Justify the Price?
No comments:
Post a Comment